サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1432280

アセトアミノフェン注射剤の世界市場：市場シェアおよびランキング・全体の売上および需要予測 (2024-2030年)

Acetaminophen Injection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
出版日: | 発行: QYResearch | ページ情報: 英文 103 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
アセトアミノフェン注射剤の世界市場：市場シェアおよびランキング・全体の売上および需要予測 (2024-2030年)
出版日: 2024年02月26日
発行: QYResearch
ページ情報: 英文 103 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアセトアミノフェン注射剤の市場規模は、2023年の7億1,968万米ドルから、予測期間中は2.97%のCAGRで推移し、2030年には9億1,204万米ドルの規模に成長すると予測されています。

北米市場は2023年の2億7,780万米ドルから、2.37％のCAGRで推移し、2030年には3億3,617万米ドルに達すると予測されています。アジア太平洋市場は、2023年の1億1,609万米ドルから、23.99％のCAGRで推移し、2030年には1億6,058万米ドルに達すると予測されています。欧州市場は2023年の2億1,391万米ドルから、3.21％のCAGRで推移し、2030年には2億7,299万米ドルに達すると予測されています。

当レポートでは、世界のアセトアミノフェン注射剤の市場を調査し、市場および製品の概要、市場成長への各種影響因子の分析、市場規模の推移・予測、タイプ・用途別の内訳、地域・主要国別の詳細分析、競合環境、市場シェア、ランキング、主要企業のプロファイルなどをまとめています。

目次

第1章 市場概要

  • アセトアミノフェン注射剤：製品概要
  • 世界市場の規模・予測
  • 市場動向・促進要因
    • 産業動向
    • 市場促進要因・機会
    • 市場課題
  • 前提と制限
  • 調査目的
  • 調査年数

第2章 競合分析：企業別

  • 主要企業の収益ランキング
  • 収益：企業別
  • 主要企業の製造拠点の分布・本社
  • 主要企業の設立日
  • 競合分析
  • M&A、拡大

第3章 タイプ別セグメント

  • タイプ別概要
    • 10mg/mL
    • 100mg/mL
    • 150mg/mL
  • 販売額
    • 販売額：2019 vs 2023 vs 2030
    • 販売額の推移・予測
    • 販売額の推移・予測 (%)

第4章 用途別セグメント

  • 用途別概要
    • 病院
    • 診療所
  • 販売額
    • 販売額：2019 vs 2023 vs 2030
    • 販売額の推移・予測
    • 販売額の推移・予測 (%)

第5章 地域別セグメント

  • 販売額
    • 販売額：2019 vs 2023 vs 2030
    • 販売額の推移
    • 販売額の予測
    • 販売額の推移・予測 (%)
  • 北米
  • 欧州
  • アジア太平洋
  • 南米・中東・アフリカ

第6章 主要国/地域別セグメント

  • 主要国/地域別の成長動向：2019 vs 2023 vs 2030
  • 主要国・地域別の販売額・販売数
  • 米国
  • 欧州
  • 中国
  • 日本
  • 韓国
  • インド

第7章 企業プロファイル

  • Mallinckrodt
  • Sandoz
  • Pfizer
  • Fresenius Kabi
  • Terumo
  • B. Braun Medical Inc
  • Eugia
  • Accord Healthcare
  • Hikma

第8章 産業チェーン分析

  • 産業チェーン
  • 上流分析
  • 中流分析
  • 下流分析（顧客分析）
  • 販売モデルと販売チャネル

第9章 調査結果・総論

第10章 付録

図表

List of Tables

  • Table 1. Acetaminophen Injection Market Trends
  • Table 2. Acetaminophen Injection Market Drivers & Opportunity
  • Table 3. Acetaminophen Injection Market Challenges
  • Table 4. Global Acetaminophen Injection Revenue by Company (2019-2024) & (US$ Million)
  • Table 5. Global Acetaminophen Injection Revenue Market Share by Company (2019-2024)
  • Table 6. Key Companies Acetaminophen Injection Manufacturing Base Distribution and Headquarters
  • Table 7. Established Date of Key Companies
  • Table 8. Global Acetaminophen Injection Companies Market Concentration Ratio (CR5)
  • Table 9. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acetaminophen Injection as of 2023)
  • Table 10. Mergers & Acquisitions, Expansion Plans
  • Table 11. Global Acetaminophen Injection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 12. Global Acetaminophen Injection Sales Value by Type (2019-2024) & (US$ Million)
  • Table 13. Global Acetaminophen Injection Sales Value by Type (2025-2030) & (US$ Million)
  • Table 14. Global Acetaminophen Injection Sales Market Share in Value by Type (2019-2024)
  • Table 15. Global Acetaminophen Injection Sales Market Share in Value by Type (2025-2030)
  • Table 16. Global Acetaminophen Injection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 17. Global Acetaminophen Injection Sales Value by Application (2019-2024) & (US$ Million)
  • Table 18. Global Acetaminophen Injection Sales Value by Application (2025-2030) & (US$ Million)
  • Table 19. Global Acetaminophen Injection Sales Market Share in Value by Application (2019-2024)
  • Table 20. Global Acetaminophen Injection Sales Market Share in Value by Application (2025-2030)
  • Table 21. Global Acetaminophen Injection Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
  • Table 22. Global Acetaminophen Injection Sales Value by Region (2019-2024) & (US$ Million)
  • Table 23. Global Acetaminophen Injection Sales Value by Region (2025-2030) & (US$ Million)
  • Table 24. Global Acetaminophen Injection Sales Value by Region (2019-2024) & (%)
  • Table 25. Global Acetaminophen Injection Sales Value by Region (2025-2030) & (%)
  • Table 26. Key Countries/Regions Acetaminophen Injection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
  • Table 27. Key Countries/Regions Acetaminophen Injection Sales Value, (2019-2024) & (US$ Million)
  • Table 28. Key Countries/Regions Acetaminophen Injection Sales Value, (2025-2030) & (US$ Million)
  • Table 29. China Recent Developments
  • Table 30. Mallinckrodt Basic Information List
  • Table 31. Mallinckrodt Description and Business Overview
  • Table 32. Mallinckrodt Acetaminophen Injection Products, Services and Solutions
  • Table 33. Revenue (US$ Million) in Acetaminophen Injection Business of Mallinckrodt (2019-2024)
  • Table 34. Mallinckrodt Recent Developments
  • Table 35. Sandoz Basic Information List
  • Table 36. Sandoz Description and Business Overview
  • Table 37. Sandoz Acetaminophen Injection Products, Services and Solutions
  • Table 38. Revenue (US$ Million) in Acetaminophen Injection Business of Sandoz (2019-2024)
  • Table 39. Sandoz Recent Developments
  • Table 40. Pfizer Basic Information List
  • Table 41. Pfizer Description and Business Overview
  • Table 42. Pfizer Acetaminophen Injection Products, Services and Solutions
  • Table 43. Revenue (US$ Million) in Acetaminophen Injection Business of Pfizer (2019-2024)
  • Table 44. Fresenius Kabi Basic Information List
  • Table 45. Fresenius Kabi Description and Business Overview
  • Table 46. Fresenius Kabi Acetaminophen Injection Products, Services and Solutions
  • Table 47. Revenue (US$ Million) in Acetaminophen Injection Business of Fresenius Kabi (2019-2024)
  • Table 48. Fresenius Kabi Recent Developments
  • Table 49. Terumo Basic Information List
  • Table 50. Terumo Description and Business Overview
  • Table 51. Terumo Acetaminophen Injection Products, Services and Solutions
  • Table 52. Revenue (US$ Million) in Acetaminophen Injection Business of Terumo (2019-2024)
  • Table 53. B. Braun Medical Inc Basic Information List
  • Table 54. B. Braun Medical Inc Description and Business Overview
  • Table 55. B. Braun Medical Inc Acetaminophen Injection Products, Services and Solutions
  • Table 56. Revenue (US$ Million) in Acetaminophen Injection Business of B. Braun Medical Inc (2019-2024)
  • Table 57. Eugia Basic Information List
  • Table 58. Eugia Description and Business Overview
  • Table 59. Eugia Acetaminophen Injection Products, Services and Solutions
  • Table 60. Revenue (US$ Million) in Acetaminophen Injection Business of Eugia (2019-2024)
  • Table 61. Eugia Recent Developments
  • Table 62. Accord Healthcare Basic Information List
  • Table 63. Accord Healthcare Description and Business Overview
  • Table 64. Accord Healthcare Acetaminophen Injection Products, Services and Solutions
  • Table 65. Revenue (US$ Million) in Acetaminophen Injection Business of Accord Healthcare (2019-2024)
  • Table 66. Hikma Basic Information List
  • Table 67. Hikma Description and Business Overview
  • Table 68. Hikma Acetaminophen Injection Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Acetaminophen Injection Business of Hikma (2019-2024)
  • Table 70. Hikma Recent Developments
  • Table 71. Key Raw Materials Lists
  • Table 72. Raw Materials Key Suppliers Lists
  • Table 73. Acetaminophen Injection Downstream Customers
  • Table 74. Acetaminophen Injection Distributors List
  • Table 75. Research Programs/Design for This Report
  • Table 76. Key Data Information from Secondary Sources
  • Table 77. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Acetaminophen Injection Product Picture
  • Figure 2. Global Acetaminophen Injection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 3. Global Acetaminophen Injection Sales Value (2019-2030) & (US$ Million)
  • Figure 4. Acetaminophen Injection Report Years Considered
  • Figure 5. Global Acetaminophen Injection Players Revenue Ranking (2023)
  • Figure 6. The 5 Largest Companies in the World: Market Share by Acetaminophen Injection Revenue in 2023
  • Figure 7. Acetaminophen Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
  • Figure 8. 10 mg/ mL Picture
  • Figure 9. 100 mg/mL Picture
  • Figure 10. 150 mg/mL Picture
  • Figure 11. Global Acetaminophen Injection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
  • Figure 12. Global Acetaminophen Injection Sales Value Market Share by Type, 2023 & 2030
  • Figure 13. Product Picture of Hospital
  • Figure 14. Product Picture of Clinic
  • Figure 15. Global Acetaminophen Injection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
  • Figure 16. Global Acetaminophen Injection Sales Value Market Share by Application, 2023 & 2030
  • Figure 17. North America Acetaminophen Injection Sales Value (2019-2030) & (US$ Million)
  • Figure 18. North America Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
  • Figure 19. Europe Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 20. Europe Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
  • Figure 21. Asia Pacific Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 22. Asia Pacific Acetaminophen Injection Sales Value by Region (%), 2023 VS 2030
  • Figure 23. South America Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 24. Middle East & Africa Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 25. South America, Middle East & Africa Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
  • Figure 26. United States Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 27. United States Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • Figure 28. United States Acetaminophen Injection Sales Value by Application (%), 2023 VS 2030
  • Figure 29. Europe Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 30. Europe Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • Figure 31. Europe Acetaminophen Injection Sales Value by Application (%), 2023 VS 2030
  • Figure 32. China Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 33. Japan Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 34. Japan Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • Figure 35. Japan Acetaminophen Injection Sales Value by Application (%), 2023 VS 2030
  • Figure 36. South Korea Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 37. South Korea Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • Figure 38. South Korea Acetaminophen Injection Sales Value by Application (%), 2023 VS 2030
  • Figure 39. India Acetaminophen Injection Sales Value, (2019-2030) & (US$ Million)
  • Figure 40. India Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
  • Figure 41. India Acetaminophen Injection Sales Value by Application (%), 2023 VS 2030
  • Figure 42. Acetaminophen Injection Industrial Chain
  • Figure 43. Acetaminophen Injection Manufacturing Cost Structure
  • Figure 44. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 45. Bottom-up and Top-down Approaches for This Report
  • Figure 46. Data Triangulation
  • Figure 47. Key Executives Interviewed
目次

The global market for Acetaminophen Injection was estimated to be worth US$ 719.68 million in 2023 and is forecast to a readjusted size of US$ 912.04 million by 2030 with a CAGR of 2.97% during the forecast period 2024-2030.

North American market for Acetaminophen Injection was valued at $ 277.80 million in 2023 and will reach $ 336.17 million by 2030, at a CAGR of 2.37% during the forecast period of 2024 through 2030.

Asia-Pacific market for Acetaminophen Injection was valued at $ 116.09 million in 2023 and will reach $ 160.58 million by 2030, at a CAGR of 3.99% during the forecast period of 2024 through 2030.

Europe market for Acetaminophen Injection was valued at $ 213.91 million in 2023 and will reach $ 272.99 million by 2030, at a CAGR of 3.21% during the forecast period of 2024 through 2030.

The global key companies of Acetaminophen Injection include Hikma, Sandoz, Mallinckrodt, B. Braun Medical Inc, Eugia, Fresenius Kabi, Pfizer, Accord Healthcare, and Terumo, etc. In 2023, the global three largest players hold a share approximately 66.67% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Acetaminophen Injection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Acetaminophen Injection by region & country, by Type, and by Application.

The Acetaminophen Injection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acetaminophen Injection.

Market Segmentation

By Company

  • Mallinckrodt
  • Sandoz
  • Pfizer
  • Fresenius Kabi
  • Terumo
  • B. Braun Medical
  • Eugia
  • Accord Healthcare
  • Hikma

Segment by Type

  • 10 mg/ mL
  • 100 mg/mL
  • 150 mg/mL

Segment by Application

  • Hospital
  • Clinic

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
  • Latin America & Middle East & Africa
  • Latin America
  • Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Acetaminophen Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Acetaminophen Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Acetaminophen Injection in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Acetaminophen Injection Product Introduction
  • 1.2 Global Acetaminophen Injection Market Size Forecast (2019-2030)
  • 1.3 Acetaminophen Injection Market Trends & Drivers
    • 1.3.1 Acetaminophen Injection Industry Trends
    • 1.3.2 Acetaminophen Injection Market Drivers & Opportunity
    • 1.3.3 Acetaminophen Injection Market Challenges
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Acetaminophen Injection Players Revenue Ranking (2023)
  • 2.2 Global Acetaminophen Injection Revenue by Company (2019-2024)
  • 2.3 Key Companies Acetaminophen Injection Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Established Date
  • 2.5 Acetaminophen Injection Market Competitive Analysis
    • 2.5.1 Acetaminophen Injection Market Concentration Rate (2019-2024)
    • 2.5.2 Global 5 Largest Companies by Acetaminophen Injection Revenue in 2023
    • 2.5.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acetaminophen Injection as of 2023)
  • 2.6 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 10 mg/ mL
    • 3.1.2 100 mg/mL
    • 3.1.3 150 mg/mL
  • 3.2 Global Acetaminophen Injection Sales Value by Type
    • 3.2.1 Global Acetaminophen Injection Sales Value by Type (2019 VS 2023 VS 2030)
    • 3.2.2 Global Acetaminophen Injection Sales Value, by Type (2019-2030)
    • 3.2.3 Global Acetaminophen Injection Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital
    • 4.1.2 Clinic
  • 4.2 Global Acetaminophen Injection Sales Value by Application
    • 4.2.1 Global Acetaminophen Injection Sales Value by Application (2019 VS 2023 VS 2030)
    • 4.2.2 Global Acetaminophen Injection Sales Value, by Application (2019-2030)
    • 4.2.3 Global Acetaminophen Injection Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

  • 5.1 Global Acetaminophen Injection Sales Value by Region
    • 5.1.1 Global Acetaminophen Injection Sales Value by Region: 2019 VS 2023 VS 2030
    • 5.1.2 Global Acetaminophen Injection Sales Value by Region (2019-2024)
    • 5.1.3 Global Acetaminophen Injection Sales Value by Region (2025-2030)
    • 5.1.4 Global Acetaminophen Injection Sales Value by Region (%), (2019-2030)
  • 5.2 North America
    • 5.2.1 North America Acetaminophen Injection Sales Value, 2019-2030
    • 5.2.2 North America Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
  • 5.3 Europe
    • 5.3.1 Europe Acetaminophen Injection Sales Value, 2019-2030
    • 5.3.2 Europe Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Acetaminophen Injection Sales Value, 2019-2030
    • 5.4.2 Asia Pacific Acetaminophen Injection Sales Value by Region (%), 2023 VS 2030
  • 5.5 South America , Middle East & Africa
    • 5.5.1 South America , Middle East & Africa Acetaminophen Injection Sales Value, 2019-2030
    • 5.5.2 South America, Middle East & Africa Acetaminophen Injection Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Acetaminophen Injection Sales Value Growth Trends, 2019 VS 2023 VS 2030
  • 6.2 Key Countries/Regions Acetaminophen Injection Sales Value, 2019-2030
  • 6.3 United States
    • 6.3.1 United States Acetaminophen Injection Sales Value, 2019-2030
    • 6.3.2 United States Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
    • 6.3.3 United States Acetaminophen Injection Sales Value by Application, 2023 VS 2030
  • 6.4 Europe
    • 6.4.1 Europe Acetaminophen Injection Sales Value, 2019-2030
    • 6.4.2 Europe Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
    • 6.4.3 Europe Acetaminophen Injection Sales Value by Application, 2023 VS 2030
  • 6.5 China
    • 6.5.1 China Acetaminophen Injection Sales Value, 2019-2030
    • 6.5.2 China Recent Developments
  • 6.6 Japan
    • 6.6.1 Japan Acetaminophen Injection Sales Value, 2019-2030
    • 6.6.2 Japan Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
    • 6.6.3 Japan Acetaminophen Injection Sales Value by Application, 2023 VS 2030
  • 6.7 South Korea
    • 6.7.1 South Korea Acetaminophen Injection Sales Value, 2019-2030
    • 6.7.2 South Korea Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
    • 6.7.3 South Korea Acetaminophen Injection Sales Value by Application, 2023 VS 2030
  • 6.8 India
    • 6.8.1 India Acetaminophen Injection Sales Value, 2019-2030
    • 6.8.2 India Acetaminophen Injection Sales Value by Type (%), 2023 VS 2030
    • 6.8.3 India Acetaminophen Injection Sales Value by Application, 2023 VS 2030

7 Company Profiles

  • 7.1 Mallinckrodt
    • 7.1.1 Mallinckrodt Profile
    • 7.1.2 Mallinckrodt Main Business
    • 7.1.3 Mallinckrodt Acetaminophen Injection Products, Services and Solutions
    • 7.1.4 Mallinckrodt Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
    • 7.1.5 Mallinckrodt Recent Developments
  • 7.2 Sandoz
    • 7.2.1 Sandoz Profile
    • 7.2.2 Sandoz Main Business
    • 7.2.3 Sandoz Acetaminophen Injection Products, Services and Solutions
    • 7.2.4 Sandoz Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
    • 7.2.5 Sandoz Recent Developments
  • 7.3 Pfizer
    • 7.3.1 Pfizer Profile
    • 7.3.2 Pfizer Main Business
    • 7.3.3 Pfizer Acetaminophen Injection Products, Services and Solutions
    • 7.3.4 Pfizer Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.4 Fresenius Kabi
    • 7.4.1 Fresenius Kabi Profile
    • 7.4.2 Fresenius Kabi Main Business
    • 7.4.3 Fresenius Kabi Acetaminophen Injection Products, Services and Solutions
    • 7.4.4 Fresenius Kabi Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
    • 7.4.5 Fresenius Kabi Recent Developments
  • 7.5 Terumo
    • 7.5.1 Terumo Profile
    • 7.5.2 Terumo Main Business
    • 7.5.3 Terumo Acetaminophen Injection Products, Services and Solutions
    • 7.5.4 Terumo Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.6 B. Braun Medical Inc
    • 7.6.1 B. Braun Medical Inc Profile
    • 7.6.2 B. Braun Medical Inc Main Business
    • 7.6.3 B. Braun Medical Inc Acetaminophen Injection Products, Services and Solutions
    • 7.6.4 B. Braun Medical Inc Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.7 Eugia
    • 7.7.1 Eugia Profile
    • 7.7.2 Eugia Main Business
    • 7.7.3 Eugia Acetaminophen Injection Products, Services and Solutions
    • 7.7.4 Eugia Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
    • 7.7.5 Eugia Recent Developments
  • 7.8 Accord Healthcare
    • 7.8.1 Accord Healthcare Profile
    • 7.8.2 Accord Healthcare Main Business
    • 7.8.3 Accord Healthcare Acetaminophen Injection Products, Services and Solutions
    • 7.8.4 Accord Healthcare Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
  • 7.9 Hikma
    • 7.9.1 Hikma Profile
    • 7.9.2 Hikma Main Business
    • 7.9.3 Hikma Acetaminophen Injection Products, Services and Solutions
    • 7.9.4 Hikma Acetaminophen Injection Revenue (US$ Million) & (2019-2024)
    • 7.9.5 Hikma Recent Developments

8 Industry Chain Analysis

  • 8.1 Acetaminophen Injection Industrial Chain
  • 8.2 Acetaminophen Injection Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Acetaminophen Injection Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Acetaminophen Injection Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
    • 10.1.2 Data Source
  • 10.2 Author Details
  • 10.3 Disclaimer